Imitrex/Naproxen NDA Slated For 2005
GlaxoSmithKline and Pozen expect to submit an NDA for the acute migraine therapy sumatriptan/naproxen in the second half of 2005
GlaxoSmithKline and Pozen expect to submit an NDA for the acute migraine therapy sumatriptan/naproxen in the second half of 2005